Harpoon Therapeutics, Inc.·4

Jul 6, 6:37 PM ET

Chin Mark 4

4 · Harpoon Therapeutics, Inc. · Filed Jul 6, 2023

Insider Transaction Report

Form 4
Period: 2023-07-01
Chin Mark
Director10% Owner
Transactions
  • Award

    Common Stock

    2023-07-01+18,65636,941 total
Footnotes (1)
  • [F1]Represents shares of common stock issuable upon the settlement of restricted stock units ("RSUs"). The fully vested RSUs were granted to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $12,500.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION